The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Chronic inorganic arsenic exposure induces hepatic global and individual gene hypomethylation: implications for arsenic hepatocarcinogenesis
Abstract
Inorganic arsenic is a human carcinogen that can target the liver, but its carcinogenic mechanisms are still unknown. Global DNA hypomethylation occurs during arsenic-induced malignant transformation in rodent liver cells. DNA hypomethylation can increase gene expression, particularly when occurring in the promoter region CpG sites, and may be a non-genotoxic mechanism of carcinogenesis. Thus, in the present study liver samples of male mice exposed to 0 (control) or 45 p.p.m. arsenic (as NaAsO(2)) in the drinking water for 48 weeks were analyzed for gene expression and DNA methylation. Chronic arsenic exposure caused hepatic steatosis, a lesion also linked to consumption of methyl-deficient diets. Microarray analysis of liver samples showed arsenic induced aberrant gene expression including steroid-related genes, cytokines, apoptosis-related genes and cell cycle-related genes. In particular, the expression of the estrogen receptor-alpha (ER-alpha), and cyclin D1 genes were markedly increased. RT-PCR and immunohistochemistry confirmed arsenic-induced increases in hepatic ER-alpha and cyclin D1 transcription and translation products, respectively. Arsenic induced hepatic global DNA hypomethylation, as evidenced by 5-methylcytosine content of DNA and by the methyl acceptance assay. Arsenic also markedly reduced the methylation within the ER-alpha gene promoter region, as assessed by methylation-specific PCR, and this reduction was statistically significant in 8 of 13 CpG sites within the promoter region. Overall, in controls 28.3% of the ER-alpha promoter region CpG sites were methylated, but only 2.9% were methylated after chronic arsenic exposure. Thus, long-term exposure of mice to arsenic in the drinking water can induce aberrant gene expression, global DNA hypomethylation, and the hypomethylation of the ER-alpha gene promoter, all of which could potentially contribute to arsenic hepatocarcinogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
(1997) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,928
High sensitivity mapping of methylated cytosines
Susan, J. C., Harrison, J., Paul, C. L., & Frommer, M. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.2990 · Cited by 1,862
Steroid hormone receptors: Many Actors in search of a plot
Beato, M., Herrlich, P., & Schütz, G. (1995) · Cell · doi:10.1016/0092-8674(95)90201-5 · Cited by 1,823
(1999) · National Academies Press eBooks · doi:10.17226/6444 · Cited by 787
Molecular Mechanisms of Estrogen Carcinogenesis
Yager, J. D., & Leihr, J. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.001223 · Cited by 654
Zhao, C. Q., Young, M. R., Diwan, B. A., Coogan, T. P., & Waalkes, M. P. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.20.10907 · Cited by 559 · cited 4×
“This is consistent with our prior in vitro work showing genome-wide hypomethylation and concurrent aberrant gene expression in liver cells malignantly transformed by arsenic ( 9 ,10).”
BackgroundResultSelf-citationOttaviano, Y. L., Issa, J. J., Parl, F. F., Smith, H. S., Baylin, S. B., & Davidson, N. E. (1994) · PubMed · Cited by 481
Epidemiological characteristics and risk factors of hepatocellular carcinoma
CHEN, C., YU, M., & LIAW, Y. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00513.x · Cited by 470
Function of a human cyclin gene as an oncogene.
Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., & Weinberg, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.709 · Cited by 454
Prall, O. J., Sarcevic, B., Musgrove, E. A., Watts, C. W., & Sutherland, R. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.16.10882 · Cited by 444
ENZYMATIC METHYLATION OF ARSENIC SPECIES AND OTHER NEW APPROACHES TO ARSENIC TOXICITY
Aposhian, H. V. (1997) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.37.1.397 · Cited by 426
The role of biomethylation in toxicity and carcinogenicity of arsenic: a research update.
Stýblo, M., Drobná, Z., Jaspers, I., Lin, S., & Thomas, D. J. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.110-1241242 · Cited by 389
Drinking water arsenic in Utah: A cohort mortality study.
Lewis, D. R., Southwick, J. W., Ouellet-Hellstrom, R., Rench, J., & Calderon, R. L. (1999) · Environmental Health Perspectives · doi:10.1289/ehp.99107359 · Cited by 372
Methylation of Inorganic Arsenic in Different Mammalian Species and Population Groups
Vahter, M. (1999) · Science Progress · doi:10.1177/003685049908200104 · Cited by 370
Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis
Hoffman, R. M. (1984) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(84)90019-2 · Cited by 349
Waalkes, M. P., Ward, J. M., Liu, J., & Diwan, B. A. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00022-4 · Cited by 343
Zingg, J. (1997) · Carcinogenesis · doi:10.1093/carcin/18.5.869 · Cited by 321
DNA Methylation in Folate Deficiency: Use of CpG Methylase
Balaghi, M., & Wagner, C. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1750 · Cited by 279
DNA Methylation and Environmental Exposures in Human Hepatocellular Carcinoma
Shen, L. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.10.755 · Cited by 249
Persson, I. (2000) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(00)00113-8 · Cited by 236
Belinsky, S. A., Nikula, K. J., Baylin, S. B., & Issa, J. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4045 · Cited by 235
Rossman, T. G., Uddin, A. N., Burns, F. J., & Bosland, M. C. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9277 · Cited by 224
Wei, M., Wanibuchi, H., Morimura, K., Iwai, S., Yoshida, K., Endo, G., Nakae, D., & Fukushima, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1387 · Cited by 222 · cited 3×
“Although at one time, arsenic was thought to be an equivocal carcinogen, that was clearly carcinogenic in humans but not active in rodents, there is accumulating evidence that arsenicals can be carcinogenic in animals (8,52,55, 56 ,57).”
BackgroundInfluentialArsenic Enhancement of Skin Neoplasia by Chronic Stimulation of Growth Factors
Germolec, D. R., Spalding, J., Yu, H.-S., Chen, G. S., Simeonova, P. P., Humble, M. C., Bruccoleri, A., Boorman, G. A., Foley, J. F., Yoshida, T., et al. (1998) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65692-1 · Cited by 200
Hepatocellular carcinoma results from chronic cyclin D1 overexpression in transgenic mice.
Deane, N. G., Parker, M. A., Aramandla, R., Diehl, L., Lee, W. J., Washington, M. K., Nanney, L., Shyr, Y., & Beauchamp, R. D. (2001) · PubMed · Cited by 199
The Role of Biomethylation in Toxicity and Carcinogenicity of Arsenic: A Research Update
Sty'blo, M., Drobná, Z., Jaspers, I., Lin, S., & Thomas, D. J. (2002) · Environmental Health Perspectives · doi:10.1289/ehp.02110s5767 · Cited by 179
Waalkes, M. P., Liu, J., Chen, H., Xie, Y., Achanzar, W. E., Zhou, Y.-S., Cheng, M.-L., & Diwan, B. A. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh070 · Cited by 176
Self-citationGehrke, C. W., McCune, R. A., Gama-Sosa, M. A., Ehrlich, M., & Kuo, K. C. (1984) · Journal of Chromatography A · doi:10.1016/s0021-9673(01)89189-5 · Cited by 172
The relationship of DNA methylation to cancer.
Bird, A. P. (1996) · PubMed · Cited by 156
Waalkes, M. P., Ward, J. M., & Diwan, B. A. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg181 · Cited by 155
Chen, H., Liu, J., Zhao, C. Q., Diwan, B. A., Merrick, B. A., & Waalkes, M. P. (2001) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2001.9253 · Cited by 142
Self-citationVogt, B. L., & Rossman, T. G. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00137-3 · Cited by 137
The 5-Methylcytosine content of highly repeated sequences in human DNA
Gama-Sosa, M. A., Wang, R. Y. ‐., Kuo, K. C., Gehrke, C. W., & Ehrlich, M. (1983) · Nucleic Acids Research · doi:10.1093/nar/11.10.3087 · Cited by 133
DNA methylation and hepatocarcinogenesis in rats fed a choline-devoid diet
Locker, J. D., Reddy, T. V., & Lombardi, B. (1986) · Carcinogenesis · doi:10.1093/carcin/7.8.1309 · Cited by 125
Okoji, R. S., Yu, R. C., Maronpot, R. R., & Froines, J. R. (2002) · Carcinogenesis · doi:10.1093/carcin/23.5.777 · Cited by 118
Waalkes, M. P., Keefer, L. K., & Diwan, B. A. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.2000.8963 · Cited by 112
Sibani, S. (2002) · Carcinogenesis · doi:10.1093/carcin/23.1.61 · Cited by 112
Altered DNA Methylation: A Secondary Mechanism Involved in Carcinogenesis
Goodman, J. I., & Watson, R. E. (2002) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.092001.141143 · Cited by 111
Sodium Arsenite-Induced Dysregulation of Proteins Involved in Proliferative Signaling
Trouba, K. J., Wauson, E., & Vorce, R. L. (2000) · Toxicology and Applied Pharmacology · doi:10.1006/taap.1999.8873 · Cited by 109
Pazzaglia, S., Mancuso, M., Primerano, B., Rebessi, S., Biozzi, G., Covelli, V., & Saran, A. (2001) · Molecular Carcinogenesis · Cited by 106
Tsujiuchi, T., Tsutsumi, M., Sasaki, Y., Takahama, M., & Konishi, Y. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00834.x · Cited by 101
Pogribny, I. P., & James, S. J. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00408-1 · Cited by 93
Poirier, L. A. (2002) · Journal of Nutrition · doi:10.1093/jn/132.8.2336s · Cited by 86
Methyl Group Deficiency in Hepatocarcinogenesis
Poirier, L. A. (1994) · Drug Metabolism Reviews · doi:10.3109/03602539409029790 · Cited by 82
Couse, J. F., Davis, V. L., Hanson, R. B., Jefferson, W. N., McLachlan, J. A., Bullock, B. C., Newbold, R. R., & Korach, K. S. (1997) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199708)19:4<236::aid-mc4>3.0.co;2-a · Cited by 76
Molecular Mechanisms of Estrogen Carcinogenesis
Yager, J. D. (1996) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.36.1.203 · Cited by 63
Tissue‐specific expression of multiple mRNA variants of the mouse estrogen receptor α gene
Koš, M., O'Brien, S., Flouriot, G., & Gannon, F. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01750-6 · Cited by 59
Hypomethylation of DNA: a nongenotoxic mechanism involved in tumor promotion
Counts, J. L., & Goodman, J. I. (1995) · Toxicology Letters · doi:10.1016/0378-4274(95)03512-5 · Cited by 55
Counts, J. L., McClain, R. M., & Goodman, J. I. (1997) · Molecular Carcinogenesis · Cited by 33
Sex Hormones and Neoplasia: Liver Tumors in Rodents
Metzler, M., & Degen, G. H. (1987) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-71617-1_23 · Cited by 22
Cited by
Scientific Opinion on Arsenic in Food
(CONTAM), E. P. O. C. I. T. F. C. (2009) · EFSA Journal · doi:10.2903/j.efsa.2009.1351 · Cited by 1,128
Human Health Effects From Chronic Arsenic Poisoning–A Review
KAPAJ, S., PETERSON, H., LIBER, K., & BHATTACHARYA, P. (2006) · Journal of Environmental Science and Health, Part A · doi:10.1080/10934520600873571 · Cited by 937
Epigenetics and environmental chemicals
Baccarelli, A., & Bollati, V. (2009) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32832925cc · Cited by 932
Changes in DNA Methylation Patterns in Subjects Exposed to Low-Dose Benzene
Bollati, V., Baccarelli, A., Hou, L., Bonzini, M., Fustinoni, S., Cavallo, D., Byun, H.-M., Jiang, J., Marinelli, B., Pesatori, A. C., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-2995 · Cited by 612
Environmental chemical exposures and human epigenetics
Hou, L., Zhang, X., Wang, D., & Baccarelli, A. (2012) · International Journal of Epidemiology · doi:10.1093/ije/dyr154 · Cited by 483
Metadata
- Authors
- Chen, H.
- Venue
- Carcinogenesis
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-04-01
- Volume
- 25
- Issue
- 9
- Pages
- 1779-1786
- ISSN
- 0143-3334 (ISSN-L)
- 1460-2180
- OpenAlex
- W2146282065
- Cited by
- 290
- References
- 50
- FWCI
- 15.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.